Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 3 1

Status

Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 8Other hematologic neoplasm 4Lymphoid 3Gastrointestinal 3CNS 3Sarcoma 1Plasma cell 1Genitourinary 1

Conditions

Glioblastoma 2Cardiotoxicity 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Temozolomide 610Radiotherapy 388Bevacizumab 254Magnetic Resonance Spectroscopy 203Cyclophosphamide 177Carboplatin 159Radiosurgery 146Etoposide 132Radiation 121Irinotecan 115Vincristine 114Cisplatin 102Filgrastim 100Specimen Handling 88Nivolumab 87pembrolizumab 82Lomustine 81Topotecan 73Surgical Procedures, Operative 73Doxorubicin 60Melphalan 59Carmustine 57sargramostim 53Radiotherapy, Intensity-Modulated 53Isotretinoin 53Peripheral Blood Stem Cell Transplantation 52Granulocyte Colony-Stimulating Factor 50Erlotinib Hydrochloride 50Everolimus 48Chemotherapy, Adjuvant 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Carvedilol × CNS × Clear all
NCT03418961 2025-10-08

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

SWOG Cancer Research Network

Phase 3 Recruiting
491 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Cardiotoxicity

NCT03861598 2021-09-24

Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells

West Virginia University

Phase EARLY_PHASE1 Terminated
4 enrolled
CNS

Glioblastoma

NCT03980249 2021-04-12

Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells

West Virginia University

Phase EARLY_PHASE1 Withdrawn
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡